A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and plan sponsors should be watching this spring, according to a new report. The pipeline ...

Forbes contributors publish independent expert analyses and insights. Bruce Y. Lee, M.D., MBA, covers health, medicine, wellness and science The NB.1.8.1 variant of the severe acute respiratory ...

BA.3.2, aka "cicada," is a highly mutated new COVID variant detected in the U.S.. Here's where it's spreading and what to know about symptoms and vaccines.

A new program from eMed and the NIH offers free tests and treatments, and you don't even need to leave your home.

WASHINGTON -- Trying to head off another chaotic scramble for scarce supplies, the White House said Friday it will step in to help coordinate distribution of the first drug that appears to help some ...

A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s ...

PHILADELPHIA -- Can a drug used to treat high cholesterol also treat COVID-19? It's a question researchers at Penn Medicine, in Philadelphia, are trying to answer. Two different studies in ...

Almost since the emergence of COVID-19, the U.S. has treated the disease as both a national and public health emergency. That ...

In patients with AF and COVID-19 who receive DOAC, 30-day mortality risk is similar for nirmatrelvir/ritonavir and RdRp inhibitors.